Redecol logo — Innovative sensor technology that enhances asthma management...

Redecol

Innovative sensor technology that enhances asthma management, improves patient lives, and lowers healthcare costs.

Founded 2017 Seed Total: $555.44K Health Care, Medical Devices

General Information

Company Name Redecol
Founded Year 2017
Industries Health Care, Medical Devices
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Redecol. To contact Redecol, visit redecol.co.uk.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Redecol compare?

A PDF of Redecol and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Redecol soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Redecol

Redecol is a Health Care startup founded in 2017 with a clear mission - to leverage innovative sensor technology to improve asthma management, patient well-being, and cut down healthcare costs. The company's slogan, "Innovative sensor technology that enhances asthma management, improves patient lives, and lowers healthcare costs," perfectly encapsulates their focus. Redecol's innovative sensor technology has the potential to be a game-changer in the field, not only for asthma but also for COPD, promising to significantly improve patient outcomes and decrease healthcare expenses associated with these chronic diseases. The latest milestone for Redecol was the £555.44K Seed Round investment secured on 01 September 2017, with the backing of SyndicateRoom as the investors. This investment undoubtedly holds the promise of propelling Redecol further towards achieving their goals of enhancing patient lives and impacting healthcare costs. This demonstrates the confidence investors have in the potential of Redecol's technology and its impact on the healthcare industry.

Business keywords: sensor technology, asthma management, COPD, healthcare costs, patient outcomes, chronic diseases, monitoring technology, health services, innovation, patient-centric, cost reduction, health tech, digital health

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round £555.44K 1
SyndicateRoom
01 Sep 2017

Redecol Alternatives & Competitors

View All Alternatives
Redecol vs
Findair
Findair Poland

Smart inhalers that make remote asthma care a reality

Seed
16 employees
Enterprise Software, Health Care
Redecol vs
QURA, Inc.
QURA, Inc. United States

Qura's targets solving healthcare's biggest problems and unmet needs, enhancing clinical outcomes an...

Series A
4 employees
Hardware, Health Care
Redecol vs
Agis Innovations
Agis Innovations The Netherlands

Health Sensor Technology

16 employees
Hardware, Health Care

FAQ About Redecol

Innovative sensor technology that enhances asthma management, improves patient lives, and lowers healthcare costs.
Redecol was founded in 2017.
Redecol operates in Health Care and Medical Devices. Its work centres on sensor technology, asthma management, COPD and healthcare costs.
Redecol has completed 1 funding round, raising a total of $555.44K. The latest funding stage is Seed.
Top alternatives and competitors to Redecol include Findair, QURA, Inc., Agis Innovations, Conversio Health, Health Hero Network. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Redecol and Findair are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Redecol, https://bouncewatch.com/company/redecol, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes